Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East News Network.
Press releases published on July 31, 2025
AIM ImmunoTech Announces Closing of $8.0 Million Public Offering
GlobeNewswire
·
July 31, 2025
OCALA, Fla., July 31, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (the “Company”), today announced the closing of its previously announced public offering of an aggregate of 2,000,000 shares of its common stock (or pre-funded warrants …
GRI Bio Reports 6-Week Interim Biomarker Data in Ongoing Phase 2a Study in Idiopathic Pulmonary Fibrosis (“IPF”)
GlobeNewswire
·
July 31, 2025
Biomarkers at 6-week interim analysis show a positive impact on fibrogenesis, fibrolysis and potentially the initiation of a repair response The Independent Data Monitoring Committee (IDMC) has recommended to continue the study as planned as there are no …
Backslash Security to Unveil Comprehensive Vibe Coding Security Platform at Black Hat USA 2025
GlobeNewswire
·
July 31, 2025
LAS VEGAS, July 31, 2025 (GLOBE NEWSWIRE) -- Backslash Security, the vibe coding security company, today announced that its platform for securing AI coding infrastructure and code will be shown at the AI Pavilion (booth #4312) at Black Hat USA in Las Vegas …
LayerX collaborates with Google Chrome Enterprise to further protect enterprises’ extension security
GlobeNewswire
·
July 31, 2025
MOUNTAIN VIEW, Calif., July 31, 2025 (GLOBE NEWSWIRE) -- LayerX Security, the leader in protecting organizations against malicious browser extensions, has integrated its industry-leading extension risk scoring directly into Chrome for Enterprises. This new …
Palisade Bio Receives Notice of Allowance for Composition of Matter Patent Covering Lead Product Candidate PALI-2108 in China
GlobeNewswire
·
July 31, 2025
PALI-2108 is the first and only PDE4 inhibitor designed to target terminal ileum and colon for fibrostenotic Crohn’s disease (FSCD) and ulcerative colitis (UC), to address significant unmet medical needs Inflammatory Bowel Disease is a large and growing …
Supernus Pharmaceuticals Completes Acquisition of Sage Therapeutics
GlobeNewswire
·
July 31, 2025
ROCKVILLE, Md., July 31, 2025 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN) (“Supernus”) today announced that it has successfully completed its previously announced acquisition of Sage Therapeutics, Inc. (Nasdaq: SAGE) (“Sage”). “Sage …
InspireMD Announces the Appointment of Raymond W. Cohen to its Board of Directors
GlobeNewswire
·
July 31, 2025
MIAMI, July 31, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR) (“InspireMD” or the “Company”), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced the appointment of Raymond W. Cohen to its Board of …
Quoin Pharmaceuticals to Announce Second Quarter 2025 Financial Results on Thursday, August 7, 2025
GlobeNewswire
·
July 31, 2025
ASHBURN, Va., July 31, 2025 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the "Company" or "Quoin"), a late clinical-stage specialty pharmaceutical company focused on rare and orphan diseases, today announced that it plans to release its …
InspireMD Announces Combined Financings of $58 Million
GlobeNewswire
·
July 31, 2025
MIAMI, July 31, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR) (“InspireMD” or the “Company”), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced the Company has raised approximately $58 million in …
Oragenics Selects Southern Star Research as Clinical Research Organization for ONP-002 Phase IIa Trial
GlobeNewswire
·
July 31, 2025
SARASOTA, Fla., July 31, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a clinical-stage biotechnology company pioneering intranasal drug delivery for neurological conditions, today announced the selection of Southern Star Research as its …
June 2025 Quarterly Activities Report
GlobeNewswire
·
July 31, 2025
QUEBEC CITY, July 31, 2025 (GLOBE NEWSWIRE) -- West African gold producer and developer Robex Resources Inc (“Robex” or the “Company”) (TSX-V: RBX | ASX: RXR | OTC: RSRBF | Börse Frankfurt: RB4) is pleased to report on its June 2025 Quarter Activities. …
Lisata Therapeutics to Report Second Quarter 2025 Financial Results and Provide a Business Update on Thursday, August 7, 2025
GlobeNewswire
·
July 31, 2025
BASKING RIDGE, N.J., July 31, 2025 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and other …
Nautilus Biotechnology Reports Second Quarter 2025 Financial Results
GlobeNewswire
·
July 31, 2025
SEATTLE, July 31, 2025 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule proteome analysis platform, today reported financial results for the second quarter ended June 30, 2025. “In Q2, …
Discovery Announces Senior Management Appointment
GlobeNewswire
·
July 31, 2025
TORONTO, July 31, 2025 (GLOBE NEWSWIRE) -- Discovery Silver Corp. (TSX: DSV, OTCQX: DSVSF) (“Discovery” or the “Company”) today announced the appointment of Alison White to the position of Chief Financial Officer (“CFO”). The appointment is effective …
Crescent Biopharma Reports Second Quarter 2025 Financial Results and Recent Business Highlights
GlobeNewswire
·
July 31, 2025
Completed Merger with GlycoMimetics and Previously Announced $200 Million Private Financing Supporting Pipeline of Next Generation Therapeutics for Solid Tumors Recent Leadership Appointments Bring Deep Experience in Oncology Drug Development, Clinical …
Effective Date of Consolidation of Shares
GlobeNewswire
·
July 31, 2025
Vancouver, British Columbia , July 31, 2025 (GLOBE NEWSWIRE) -- First American Uranium Inc. (CSE: URM) (FSE: IOR) (OTCPK: FAUMF) (the “Company”) announces, further to its news release of July 21, 2025 and effective August 6, 2025, the Company will …
InflaRx to Report Second Quarter 2025 Results on August 7, 2025
GlobeNewswire
·
July 31, 2025
JENA, Germany, July 31, 2025 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today announced that the Company will report its second quarter 2025 …
Osisko Development Announces US$195 Million Financing
GlobeNewswire
·
July 31, 2025
Not for distribution to U.S. news wire services or dissemination in the United States. MONTREAL, July 31, 2025 (GLOBE NEWSWIRE) -- Osisko Development Corp. (NYSE: ODV, TSXV: ODV) ("Osisko Development" or the "Company") announces today that it has entered …
Apellis Pharmaceuticals Reports Second Quarter 2025 Financial Results
GlobeNewswire
·
July 31, 2025
Received U.S. FDA approval for EMPAVELI® (pegcetacoplan) for treatment of patients 12 years and older with C3G and primary IC-MPGN Announced capped royalty purchase agreement with Sobi under which Apellis receives up to $300 million for 90% of ex-U.S. …
Gilat to Present at the 28th Annual Oppenheimer Technology, Internet & Communications Virtual Conference on Monday, August 11
GlobeNewswire
·
July 31, 2025
PETAH TIKVA, Israel, July 31, 2025 (GLOBE NEWSWIRE) -- Gilat Satellite Networks Ltd. (Nasdaq: GILT, TASE: GILT), a worldwide leader in satellite networking technology, solutions, and services, today announced it will be presenting at the 28th Annual …